Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Best Practices for Anticoagulation Management After Venous Interventions
Interview
Best Practices for Anticoagulation Management After Venous Interventions
01/21/2020
Vascular Disease Management spoke with Raghu Kolluri, MD, MS, RVT, FSVM, President for the Society for Vascular Medicine and System Medical Director, Vascular Medicine at OhioHealth Riverside Methodist Hospital. Dr. Kolluri discussed...
Vascular Disease Management spoke with Raghu Kolluri, MD, MS, RVT, FSVM, President for the Society for Vascular Medicine and System Medical Director, Vascular Medicine at OhioHealth Riverside Methodist Hospital. Dr. Kolluri discussed...
Vascular Disease Management...
01/21/2020
Vascular Disease Management
Iliac Vein Chronic Total Occlusion Revascularization Using the Vici Venous Stent System
Case Report
Iliac Vein Chronic Total Occlusion Revascularization Using the Vici Venous Stent System
01/21/2020
The authors demonstrate a case of iliac vein chronic total occlusion revascularized with the Vici Venous Stent (Boston Scientific).
The authors demonstrate a case of iliac vein chronic total occlusion revascularized with the Vici Venous Stent (Boston Scientific).
The authors demonstrate a case...
01/21/2020
Vascular Disease Management
Case Report
A Patient With Spontaneous Pulmonary Embolism and Concomitant Deep Vein Thrombosis Treated With FlowTriever and ClotTriever Mechanical Thrombectomy
11/04/2019
Salimnia and colleagues describe the case of a 45-year-old man who presented with tachycardia, tachypnea, and hypoxemia.
Salimnia and colleagues describe the case of a 45-year-old man who presented with tachycardia, tachypnea, and hypoxemia.
Salimnia and colleagues describe...
11/04/2019
Vascular Disease Management
Commentary
Technology Must Meet Efficacy in Treating ALI
11/04/2019
Paul Michael, MD, comments on a single-center, observational experience of patients treated for acute limb ischemia by Estes and colleagues, and congratulates the group for wanting to constantly improve their state of thrombolysis therapy.
Paul Michael, MD, comments on a single-center, observational experience of patients treated for acute limb ischemia by Estes and colleagues, and congratulates the group for wanting to constantly improve their state of thrombolysis therapy.
Paul Michael, MD, comments on a...
11/04/2019
Vascular Disease Management
Editor's Corner
The Combination of Thrombolytic Infusion and Pulsed Ultrasonic Energy Shows Potential to Improve Outcomes
11/04/2019
Dr. Walker comments on an article about ALI, which represents one of the most severe manifestations of limb ischemia.
Dr. Walker comments on an article about ALI, which represents one of the most severe manifestations of limb ischemia.
Dr. Walker comments on an...
11/04/2019
Vascular Disease Management
Editor's Corner
Venous Intervention With Stenting is an Effective, Low-Risk Treatment for Ulcers
10/21/2019
Craig Walker, MD, comments on a case report describing the treatment of a 90-year-old man with a chronic, non-healing venous leg ulcer.
Craig Walker, MD, comments on a case report describing the treatment of a 90-year-old man with a chronic, non-healing venous leg ulcer.
Craig Walker, MD, comments on a...
10/21/2019
Vascular Disease Management
Interview
Tips for Managing Chronic Mesenteric Ischemia
07/22/2019
John Angle, MD, discusses the challenges of treating chronic mesenteric ischemia.
John Angle, MD, discusses the challenges of treating chronic mesenteric ischemia.
John Angle, MD, discusses the...
07/22/2019
Vascular Disease Management
Case Report
Experience With the Use of Perilesional and Intralesional Recombinant Human Epidermal Growth Factor (Nepidermin) in the Treatment of Patients With Chronic Venous Ulcers
01/21/2019
This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.
This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.
This study describes the results...
01/21/2019
Vascular Disease Management
Case Report
Anomalous Drainage of Inferior and Left Superior Vena Cava to the Left Atrium in an Infant Palliated With Ductal Stenting
10/22/2018
Nikolaos G. Eleftherakis, MD and Evangelos S. Karanasios, MD, report a case of anomalous drainage of inferior and left superior vena cava to the left atrium in an infant palliated with ductal stenting.
Nikolaos G. Eleftherakis, MD and Evangelos S. Karanasios, MD, report a case of anomalous drainage of inferior and left superior vena cava to the left atrium in an infant palliated with ductal stenting.
Nikolaos G. Eleftherakis, MD and...
10/22/2018
Vascular Disease Management
Intervew
The ATTRACT Trial: Understanding the Results
05/16/2018
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute DVT. Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the trial and takeaways for...
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute DVT. Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the trial and takeaways for...
The recent publication of the...
05/16/2018
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement